pentachlorophenol has been researched along with Hemorrhage in 5 studies
PENTA: structure given in first source
Hemorrhage: Bleeding or escape of blood from a vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It strongly inhibited thrombus formation in an experimental model of thromboplastin-induced venous thrombosis in rats (intravenously) and rabbits (subcutaneously) (ED50 values were 25." | 3.69 | Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin. ( Bernat, A; Hérault, JP; Herbert, JM; Lormeau, JC; Meuleman, DG; Petitou, M; van Amsterdam, RG; Vogel, GM, 1996) |
| "Venous thromboembolism is a frequent complication of total hip replacement." | 2.70 | A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. ( Gallus, AS; Hoek, JA; Turpie, AG, 2001) |
| " administration, as expected because of the approximately 100% bioavailability of the anti-Xa activity after s." | 1.28 | Pharmacological profile of the chemically synthesized antithrombin III binding fragment of heparin (pentasaccharide) in rats. ( Hobbelen, PM; Meuleman, DG; Moelker, HC; van Boeckel, CA; van Dinther, TG; Vogel, GM, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herbert, JM | 3 |
| Hérault, JP | 1 |
| Bernat, A | 3 |
| van Amsterdam, RG | 1 |
| Vogel, GM | 2 |
| Lormeau, JC | 1 |
| Petitou, M | 1 |
| Meuleman, DG | 2 |
| Hoffmann, P | 2 |
| Savi, P | 1 |
| Lale, A | 1 |
| Turpie, AG | 1 |
| Gallus, AS | 1 |
| Hoek, JA | 1 |
| Hobbelen, PM | 1 |
| van Dinther, TG | 1 |
| van Boeckel, CA | 1 |
| Moelker, HC | 1 |
1 trial available for pentachlorophenol and Hemorrhage
| Article | Year |
|---|---|
A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Dose-Res | 2001 |
4 other studies available for pentachlorophenol and Hemorrhage
| Article | Year |
|---|---|
Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin.
Topics: Animals; Anticoagulants; Electric Stimulation; Factor Xa Inhibitors; Fibrinogen; Fibrinolytic Agents | 1996 |
Antagonism of SR 90107A/Org 31540-induced bleeding by protamine sulfate in rats and mice.
Topics: Animals; Bleeding Time; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Heparin; Heparin Anta | 1996 |
The antithrombotic efficacy of the GP IIb/IIIa antagonist SR121787 is potentiated by antithrombin-dependent factor Xa inhibition without an increase in the bleeding risk in the rabbit.
Topics: Animals; Anticoagulants; Antithrombins; Benzylamines; Carotid Arteries; Disease Models, Animal; Drug | 1999 |
Pharmacological profile of the chemically synthesized antithrombin III binding fragment of heparin (pentasaccharide) in rats.
Topics: Animals; Antithrombin III; Carbohydrate Sequence; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrh | 1990 |